Hagino H

No ORCID on file · 2 papers in corpus
nonrandomized-trial 2009
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/j.1447-0756.2009.01076.x

AIM: To investigate the safety and efficacy of 52 weeks of dienogest treatment in patients with endometriosis. METHODS: One hundred and thirty-five patients with endometriosis received 2 mg of dienogest orally each day for 52 weeks. Advers…

rct 2008
Fertility and sterility ·doi:10.1016/j.fertnstert.2007.12.080

OBJECTIVE: To compare the efficacy and safety of dienogest (DNG) with intranasal buserelin acetate (BA) in patients with endometriosis. DESIGN: Phase III, randomized, double-blind, multicenter, controlled trial. SETTING: Twenty-four study…